Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Depreciation & Amortization (CF) (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Depreciation & Amortization (CF) readings, the most recent being $270000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 10.6% to $270000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, up 3.48% year-over-year, with the annual reading at $1.2 million for FY2025, 10.21% up from the prior year.
  • Depreciation & Amortization (CF) hit $270000.0 in Q1 2026 for Oric Pharmaceuticals, down from $320000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $320000.0 in Q4 2025 and bottomed at $221000.0 in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $270411.8, with a median of $270000.0 recorded in 2024.
  • The largest annual shift saw Depreciation & Amortization (CF) decreased 17.79% in 2023 before it surged 31.6% in 2024.
  • Oric Pharmaceuticals' Depreciation & Amortization (CF) stood at $281000.0 in 2022, then dropped by 17.79% to $231000.0 in 2023, then skyrocketed by 31.6% to $304000.0 in 2024, then increased by 5.26% to $320000.0 in 2025, then decreased by 15.62% to $270000.0 in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Depreciation & Amortization (CF) are $270000.0 (Q1 2026), $320000.0 (Q4 2025), and $288000.0 (Q3 2025).